Marktplatzangebote
Ein Angebot für € 127,82 €
  • Broschiertes Buch

Advances in Ultra-low Emission Control Technologies for Coal-Fired Power Plants discusses the emissions standards of dust, SO2, NOx and mercury pollution, also presenting the key technologies available to control emissions in coal-fired power plants. The practical effects of ultra-low emissions projects included help the reader understand related implications in plants. Emphasis is placed on 300MW subcritical, 600MW subcritical, 660MW supercritical and 1000MW ultra-supercritical coal-fired units. The influence of different pollutant control units, such as wet electrostatic precipitator,…mehr

Produktbeschreibung
Advances in Ultra-low Emission Control Technologies for Coal-Fired Power Plants discusses the emissions standards of dust, SO2, NOx and mercury pollution, also presenting the key technologies available to control emissions in coal-fired power plants. The practical effects of ultra-low emissions projects included help the reader understand related implications in plants. Emphasis is placed on 300MW subcritical, 600MW subcritical, 660MW supercritical and 1000MW ultra-supercritical coal-fired units. The influence of different pollutant control units, such as wet electrostatic precipitator, desulfurization equipment and the electrostatic precipitator are also analyzed, and the pollutant levels before and after retrofitted ultra-low emissions are compared throughout.
Autorenporträt
Professor Zhang began his career as a Technician at Labor Industrial Company of Shanxi Province, China, before working as a Post-doctoral research fellow at Institute of Engineering Thermophysics, Chinese Academy Sciences. He lectured at the Faculty of School of Energy, Power and Mechanical Engineering, North China Electric Power University, and is now an Professor specializing in Mechanical, Environmental Chemistry and Chemical Engineering. He has published over 400 journals across Elsevier journals such as Fuel and Journal of Environmental Sciences.Dr. Wang obtained an MD from Norman Bethune University of Medical Sciences in China, a PhD in Toxicology from University of Louisiana, and is a Diplomat of the American Board of Toxicology. Dr. Wang's professional experience includes clinical practice in oncology, research on gene regulation in an academic setting, and more than 20 years of professional practice as toxicologist in the pharmaceutical/biotech industry. She is currently the Executive Director of Translational & Development Sciences at Coherus BioSciences, where she oversees preclinical development (in vivo pharmacokinetics, pharmacology and toxicology of small molecules and biologics) of drug candidates from early through late stage development. Prior to joining Coherus, Dr. Wang worked at Novartis Pharmaceuticals and Achaogen, where she led safety assessment efforts for oncology and non-oncology drug development. Dr. Wang received multiple professional awards, recognizing her significant achievements and performanc

e above and beyond work requirements (e.g. Novartis Above & Beyond, Due Diligence, Catalyst Awards, and Spot Awards). She was also acknowledged for outstanding collaboration and contributions on multidisciplinary teams (e.g., Novartis Team Award). Dr. Wang is an active member with Society of Toxicology (SOT), and has contributed to the society's leadership team as a Councilor and by serving on numerous elected and appointed committees. She also served on the Board of Directors for the American Board of Toxicology (ABT) and is an advisor to the Education Committee at International Union of Toxicology (IUTOX). Dr. Wang is on the Editorial Boards of the International Journal of Toxicology and Toxicology Research and Application. Dr. Wang has taught a course on Practical Toxicology at the University of California at Berkeley as a guest lecturer.